Myelofibrosis and Polycythemia Vera: Current and Emerging Treatment Options

This comprehensive program gathers insight from 5 experts to improve the skills of clinicians who treat patients with myeloproliferative neoplasms particularly myelofibrosis and polycythemia vera. All aspects of this program are designed to complement each other including an Interactive Treatment Decision Support Tool an expert-authored commentary and module and a downloadable slideset.

Share

Program Content

Activities

MF/PV Studies at Hematology 2016
My Thoughts on Key Myelofibrosis and Polycythemia Vera Management Studies From the Hematology 2016 Meeting
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 30, 2016

Expires: December 29, 2017

Activities

Downloadable Slideset
Myelofibrosis and Polycythemia Vera: Current and Emerging Treatment Options
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 08, 2017

Expires: May 07, 2018

Faculty

cover img faculity

Brady L. Stein, MD, MHS

Professor of Medicine
Department of Hematology/Oncology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from

Incyte